4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-013702
Chief Financial Officer sold 398 shares at $10.71 ($4,263)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Trigilio Jeffrey Chief Financial Officer | 2023-04-18 | Sale | −398 | $10.71 | $4,263 | 87,287 | D |
| Open-market sales · 398 sh · avg $10.71 · $4,263 | |||||||
Loading xslF345X04/ownership.xml…